NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

11 hedge funds and large institutions have $196K invested in Northwest Biotherapeutics, Inc. Common stock in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VWA
1
VSM Wealth Advisory
Maryland
$18K
2
MSAM
2
Moloney Securities Asset Management
Missouri
$134K
3
SL
3
Sentinus LLC
Illinois
$3.55K

Top Sellers

1
MCM
1
MAI Capital Management
Ohio
$0
2
LDB
2
Lee, Danner & Bass
Tennessee
$0
3
WJWM
3
Williams Jones Wealth Management
New York
$7.42K
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$134K 488,520 +26,305 +6%
VWA
2
VSM Wealth Advisory
Maryland
$18K 65,574 +65,574 New
OCG
3
Opus Capital Group
Ohio
$17K 60,150 – –
WJWM
4
Williams Jones Wealth Management
New York
$7.42K 27,000 -8,000 -23%
EFG
5
Ethos Financial Group
Pennsylvania
$6.51K 23,700 – –
AA
6
AlphaMark Advisors
Kentucky
$4K 14,007 – –
SL
7
Sentinus LLC
Illinois
$3.55K 12,925 +12,925 New
AMG
8
Advisors Management Group
Wisconsin
$3K 10,270 – –
KA
9
KLCM Advisors
Wisconsin
$2.75K 10,000 – –
LDB
10
Lee, Danner & Bass
Tennessee
– – -20,000 Closed
MCM
11
MAI Capital Management
Ohio
– – -20,000 Closed
HFS
12
Hantz Financial Services
Michigan
$0 250 – –
CMP
13
Coston McIsaac & Partners
Maine
$0 1,000 – –